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ABSTRACT
Objectives: To determine how common cancer of penis is in this locality compared to all other
malignant tumours and urological malignancies, and to determine and comment on the
various methods of treatment available at KNH.
Design: A retrospective case study.
Setting: Kenyatta National Referral Hospital, Nairobi.
Subjects: All patients with histologically confirmed cancer of penis at  the Kenyatta National
hospital between January 1970 and December 1999.
Results: There were 55 patients with penile cancer representing 0.1% of all malignancies
during the study period. The mean age was 47.9 years with a peak incidence between 40-61
year age groups. Penile cancer was the most rare urological tumour representing 5.1%. The
most common was prostate cancer (56.0%), followed by bladder cancer (25.0%), kidney
cancer (7.9%), and testicular cancer (6.1%). Thirty eight patients (69.1%) presented with
advanced disease, Jacksons stages III and IV. The majority (96.4%) of the patients had
glandular and preputial involvement. Histologically, 56.4% had well differentiated squamous
cell carcinoma, (23.6%) had moderately differentiated and (20.0%) had undifferentiated
carcinoma. Forty patients (72.7%) were circumcised, nine patients (16.4%) were circumcised
as adolescents and three patients (5.5%) circumcised as adults. Twenty five patients had
partial penectomy with radiotherapy and or chemotherapy. Eight patients had total
penectomy and radiotherapy while four patients had local excision and radiotherapy. Eleven
other patients had radiotherapy either alone or combined with chemotherapy. Two patients
had circumcision only and inguinal lymphadenectomy was effected on five patients after
penectomy and radiotherapy.
Conclusion: Penile cancer is rare and the least common urological malignancy in this locality.
It occurs in younger men with a mean age of 47.9 years, and presents as advanced Jackson's
stages III and IV disease. The majority of patients had penectomy and local excision followed
by radiotherapy.
INTRODUCTION
Squamous cell carcinoma of the penis accounts for
two to five per cent of genitourinary malignancies(1). The
incidence varies widely according to geographic
distribution(2) and with hygienic standards, religious and
various cultural practices among different communities
from different parts of the world(3). In the western world,
penile cancer is a rare condition accounting for less than
one per cent of all male malignancies in the United States
of America and Europe, but is much more common among
some uncircumcised African, Asian, South American and
tropical tribes where it constitutes a serious health
hazard(4). Reddy et al(5) have reported that penile cancer
occurs in 16.67% of all cancers in some parts of India,
while in Brazil the incidence varies from 2.1-17% of all
cancers(6). In South Africa, the incidence among the
African population varies between two per cent in
Transvaal(7) and seven per cent in Natal(8). In most parts
of Uganda, cancer of the penis was reported to be the
commonest malignancy in the male adult African
accounting for 12.2% of all cancers and second only to
malignant lymphoma and cancer of the cervix(9,10). The
annual Medical report for Uganda recorded 124 new
penile cancer cases in 1964, and Kyalwazi in Kampala in
1966(11) and Kyalwazi and Bhana in 1972(12) reported
the Mulago hospital annual admission rate of seventeen to
twenty two new cases per year. However, Williams
compiled a cancer register for the West Nile district of
Uganda where people do not practice ritual circumcision
and reported penile cancer in eleven of 317 malignancies
representing only 3.47%(13). Elshleman at Shirati Hospital
in the Mara region of neighbouring Tanzania, also reported
penile cancer in 4% of the 279 malignant tumours he
reviewed (14). In Kenya inhabited by the uncircumcised
Luo and the Turkana, penile cancer was previously reported
to be rare(15).
Penile cancer is virtually unknown in the Jewish
population where neonatal circumcision is routinely
practised(16). The tumour typically occurs in men in the
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sixth or seventh decades of life, but is not uncommon in
men below 40 years of age(17,18), and has also been
reported in children(19). Racial predilection has not been
clearly proven and any observed racial differences are
more likely to be due to socio-economic or environmental
factors(20).
It is against this background that this study involving
all patients diagnosed with cancer of the penis at the
Kenyatta National referral and University of Nairobi
teaching hospital over 30 years was carried out. The study
determines how common cancer of the penis is in this
locality, and the various treatment methods available.
MATERIALS AND METHODS
This was a retrospective study involving fifty five patients.
All patients who were treated at the Kenyatta National Hospital
over a 30 year period (1970-1999) with histopathologically
confirmed diagnosis of penile cancer were included in this study.
Sources of information included Urology and Radiotherapy
clinics, operating theatre records, the histopathology department,
the cancer registry and the surgical and radiotherapy wards of
Kenyatta National Hospital. The patient case notes were retrieved
from the Medical records department and all the necessary
information such as the age, clinical presentation, stage of
tumour, histological confirmation of cancer, the degree of
differentiation, circumcision status and the type of treatment
offered etc was retrieved and tabulated as shown under the
results. For comparison all cases of other malignancies admitted
to Kenyatta National Hospital over the same period was also
obtained. For the period of 1990-1999, all Urological malignancies
were obtained from the medical records department and compared
to penile cancer. All these data were analysed and tabulated .
RESULTS
Fifty five patients with histologically proven cancer
of penis were seen and treated at Kenyatta National
Hospital over a 30 year period from January 1970 to
December 1999. The distribution of penile cancer by
decade and its comparison with all other malignant tumours
is illustrated in Table 1, and indicates that cancer of penis
represents only 0.1% of all malignant tumours. The age
range was 20-80 years with a mean of 47.9 years and a
peak in the 41-60 year age group as depicted in Table 2.
Table l
Comparison of penile cancer to all other malignancies at KNH over
three decades (1970 - 1999)
Decade Total no of cancers Cancer of penis %
1st decade 1970-1979 10,677 12 0.1
2nd decade 1980-1989 18,543 17 0.1
3rd decade 1990-1999 22,796 26 0.1
Total 1970-1999 52,016 55 0.1
Cancer of penis compared to other urological
malignancies at KNH over a ten-year period is illustrated
in Table 3, indicating that cancer of penis was the least
common tumour representing 5.1% of total. The most
common urological malignancy was prostate cancer
accounting for 56.0%, followed by bladder cancer 25.0%,
kidney cancer 7.9% and testicular cancer 6.1%.
The anatomical distribution of tumour indicates 52
patients (94.6%) had glandular cancer either restricted or
spreading to the penile shaft or prepuce. Cancer was
restricted to the prepuce alone in seven patients (12.7%)
and penile shaft alone in only three patients (5.5%) as
depicted in Table 4. The histological types of tumour are
illustrated in Table 5, which indicates that the majority
(56.4%) were well differentiated squamous cell carcinoma.
Thirty eight patients had advanced disease (Jackson's
stages III and IV) as shown in Table 5.
Table 2
Age variation in penile cancer compared to other urological malignancies
Age group in yrs Penile cancer Prostrate cancer Bladder cancer Kidney cancer Testicular cancer
0-20 yrs 1 0 0 1 2
21-30 yrs 2 0 4 7 9
31-40 yrs 4 0 17 6 12
41-50 yrs 7 3 32 7 4
51-60 yrs 6 50 29 9 2
61-70 yrs 4 106 26 7 1
71-80 yrs 2 94 11 2 1
81-90 yrs 0 32 8 1 0
Total 26 285 127 40 31
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Table 3
Comparison of penile cancer with other urological cancers at KNH
(1990-1999)
Type of cancer No. of patients % of total
Cancer of prostate 285 56.0
Cancer of bladder 127 24.9
Cancer of kidney 40 7.9
Cancer of testis 31 6.1
Cancer of penis 26 5.1
Total 509 100
Table 4
Anatomical distribution in penile cancer patients at KNH (1970-
1999)
Site of primary lesion No of patients % of total
Glans penis 24 43.6
Glans and shaft of penis 12 21.8
Prepuce only 7 12.7
Glans and prepuce 4 7.3
Shaft and prepuce 3 5.5
Shaft of penis 3 5.5
Whole penis and scrotum 2 3.6
Total 55 100
Table 5
Clinical stage of penile cancer patients at KNH (1970-1999)






Histological types of penile cancer at KNH over three decades (1970-
1999)
Histological type No. of patients % of total
Well differentiated squamous cell
carcinoma 31 56.4
Moderately differentiated
squamous cell carcinoma 13 23.6
Undifferentiated (anaplastic)
squamous cell carcinoma 11 20.0
Total 55 100.0
Table 7
Circumcision status in penile cancer patients at KNH (1990-1999)
Circumcision status No of patients % of total
Uncircumcised 40 72.7
Circumcised as neonates 0 0
Circumcision status unknown 3 5.5
Total circumcised as adults, adolescents
and infants 12 21.8
Grand total 55 100.0
Table 8
Methods of treatment in penile cancer patients at KNH (1970-1999)
Type of treatment
Circumcision 2 3.6
Local excision and radiotherapy 4 7.3
Partial penectomy and radiotherapy 16 20.1
Partial penectomy and chemotherapy 3 5.5
Partial penectomy, radiotherapy and chemotherapy 6 10.9
Total penectomy and radiotherapy 8 14.5
Radiotherapy alone 5 9.1
Chemotherapy and radiotherapy 6 10.9
No definitive treatment 5 9.1
Total 55 100.00
Table 7 shows that 40 patients (72.7%) were
uncircumcised, 12 patients (21.8%) were circumcised
either in adolescence or as adults. No patient was
circumcised in infancy and circumcision status was
unknown (not recorded) in three patients (5.5%). The
various-methods of treatment are illustrated in Table 8.
DISCUSION
The findings in this study of penile cancer in only
0.1% of all malignancies treated at the  National Hospital
over 30 years indicate that  the tumour is rare with a yearly
average of about two patients despite the inclusion of the
uncircumcised Kenyan tribes such as the Luo and Turkana
in the study group. Cancer of the penis accounted for only
5.1% of all urological malignancies over a ten year period.
The commonest urological tumour was cancer of the
prostate representing 56.0%. This is in direct contrast with
the findings of Kyalwazi in Uganda who reported a yearly
admission rate of 17-22 of penile cancer at Mulago hospital
cases among the Baganda who do not routinely
circumcise(11). Earlier reports from most parts of
Uganda(9,10) also reported it as common accounting for
12.2% of all cancers. The finding of rare penile cancer in
this study conducted in Nairobi could be due to the fact that
Nairobi metropolis is surrounded by the Kikuyu, Kamba
and Maasai tribes who circumcise routinely. However,
penile cancer is not uniformly common in Uganda where
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Williams reported its presence in only 3.5% of all malignant
tumours reviewed from the West Nile district of Uganda
where ritual circumcision is not practised(13). Furthermore,
Elshleman also reported penile cancer in only 4.0% of all
malignant tumours reviewed at Shirati  hospital in northern
Tanzania(14). Burkitt in 1965 reported cancer of the penis
to be uniformly rare in some uncircumcised Ugandan
tribes such as the Acholi and the Lugbara and some tribes
of the southern highlands of Tanzania(21,22).
The age range was 20-80 years with a mean of 47.9
years and a peak incidence in the 41-60 year age groups
similar to the findings of Bhana and Kyalwazi in Uganda
in 1972 who reported a mean age of 46.5 years with a peak
in the 41-60 year age group(12). It is however widely
reported that squamous cell cancer of the penis is commoner
in men in their sixth and seventh decades with an abrupt
increase in incidence at 60 years and peaking at 80 years
of age(23). In two such studies the mean age was reported
as being 55 and 58 years(24,25) respectively. The reason
for the reported lower mean age and peak incidence of this
cancer in East Africans is not clear and needs to be
investigated further.
Cancer of the penis is usually an epidermoid tumour
arising from the glans penis or the mucosal lining of the
prepuce(26). In this study, the majority of cancers (96.4%)
had glandular and/or preputial involvement. Only three
patients (5.5%) had penile shaft tumours without the
involvement of the glans and prepuce as shown in Table 4.
The majority of patients (69.1%), presented with advanced
disease (Jackson's stages III and IV) with operable or
inoperable inguinal metastases, and tumours involving
adjacent structures or distant metastases(27). The reason
for this late presentation of penile cancer in this locality is
due to the delay in seeking appropriate medical advice as
a result of socio-cultural taboos and ignorance.
The majority of patients (72.7%) in this study were
uncircumcised. This is in conformity with numerous previous
reports that indicate penile cancer to be common among the
uncircumcised males(9-12,16). The development of tumour
in the uncircumcised men has been attributed to the chronic
irritative effects of smegma, a byproduct of bacterial action
on desquamated cells that are within the preputial sac. Such
exposure is accentuated by phimosis which is present in 25-
75% of patients in most large series(28,29). Although
definitive evidence that smegma is a carcinogen has not
been established, its relationship with penile cancer has
been widely reported(30,31). Neonatal circumcision as
practised by the Jews is known to prevent the development
of cancer of penis(32,33). However, circumcision in
adolescence and in adults does not prevent the development
of penile cancer(34,35). This is further buttressed by the
findings in this study of penile cancer in twelve circumcised
patients representing 21.8% of total as shown in Table 7.
Nine of these patients (16.4%) were circumcised during
their adolescence while three patients (5.5%) were
circumcised as adults.
The earlier research on penile cancer research in East
Africans was carried out in Uganda which was the seat of
the premier and only medical school in the region at the
time, incorporating the Mulago Hospital and located at
Makerere in Kampala(9-13,36,37). These early
investigators were faced with limited options in the
management of penile cancer as radiotherapy was not
available in Uganda at that time. They therefore offered
surgical modes of treatment such as circumcision, partial
or total amputation of penis with or without inguinal
lymph node dissection and cytotoxic chemotherapy either
alone or in addition to the various methods of surgery(11-
13,38). Radiotherapy was introduced in Kenya in 1968
through the collaboration of the Swedish government and
the Karolinska Institute of Stockholm. As a result of this
the majority of penile cancer patients treated at Kenyatta
National Hospital between 1970-1999 benefited from
radiotherapy treatment either alone, or in combination
with surgery or chemotherapy as detailed in Table 8.
In this study only two patients (3.6%) with early
preputial cancer were treated with circumcision alone.
Circumcision alone is usually followed by a high rate of
tumour recurrence in upto 32% of the cases as reported by
McDoughal(39). A total of 25 patients (45.5%) had partial
penectomy as a form of treatment. Sixteen of these patients
(20.1%) had additional external radiotherapy treatment,
while another six patients (10.9%) had both external
radiotherapy and chemotherapy in addition to partial
penectomy. The last three patients (5.5%) in this group
had partial penectomy and chemotherapy. For lesions
involving the glans and the distal shaft of penis, even when
apparently superficial, partial penectomy with a 2cm
margin proximal to the tumour is necessary to minimise
local recurrence(40). The residual penile stump after partial
penectomy is serviceable for upright micturition and
satisfactory sexual function. Four patients (7.3%) who
declined both forms of penectomy had local tumour
excision and radiotherapy. Total penectomy was performed
on eight patients (14.5%) followed by external
radiotherapy. When penile cancer is extending to and
involving the penile shaft so that partial penectomy does
not provide a 2cm tumour free margin, total penectomy
and a perineal urethrotomy is advocated. This procedure
allows the patient to void in the sitting position(2).
Five patients (9.1%) were treated with external
radiotherapy only. Two of these patients had refused any
form of surgical treatment while the other three patients had
disseminated disease. Radiotherapy, either external or
brachitherapy (surface moulds or interstitial implantation)
allows the preservation of penile structure and function in
carefully selected patients(41). Small superficial tumours
respond well to radiotherapy although squamous cell cancer
is known to be characteristically radioresistant. The use of
radiotherapy in the treatment of large invasive penile
malignancies is less successful, requires higher radiation
doses and may result in severe local complications such as
urethral fistula, stricture or stenosis with or without penile
pain and oedema, and radionecrosis of the penis(42,43).
Testicular damage and the development of secondary penile
neoplasia has also been reported(44). Six other patients
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were treated with radiotherapy and chemotherapy.
Chemotherapy has been utilised in the treatment of advanced
penile cancer either alone or in combination with surgery or
radiotherapy. Bleomycin, cisplastin and methotrexate are
the most effective but complete responses are rare(45).
Inguinal lymphadenectomy was effected on five patients
after penectomy and radiotherapy. The overall prognosis in
all stages of penile cancer is known to depend largely upon
the presence or absence of inguinal lymph node
metastases(46). Only supportive analgesic, haematinic and
antibiotic treatment was given to the five patients who had
advanced terminal disease.
Recent advances in surgical therapy including MOHS
micrographic surgery, laser therapy and reconstructive surgery
can provide satisfactory surgical treatment while minimising
functional loss of the penis and avoiding the considerable
complications associated with radiotherapy(43,47,48).
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